Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.


Thursday’s trading has closed, but PDLI is being traded in the after-hours session. After-Hours quote »
Delayed Data
As of 3:59pm ET
 +0.01 / +0.19%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for PDL BioPharma Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +35.14% increase from the last price of 5.18.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in PDL BioPharma Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 29.79%
Growthannually 16.67%


Growthquarterly 19.77%
Growthannually 5.08%
Key to the earnings and sales forecast charts.